If we accept that ongoing dialogue about access to medical oxygen is a pre-requisite during a pandemic, if not a lesson learned from this oxygen crisis of the last 18 months, then might we also argue there is discussion to be had concerning its purity and accessibility itself?
There have proven to be many lessons to be learned from this pandemic, many of which have concerned the oxygen supply chain. A range of talking points have been raised through the course of this series of articles, not least the differences between medical-grade liquid oxygen produced and the oxygen produced onsite via purpose-built pressure swing adsorption (PSA) systems.
Yet another topic altogether is the subject of industrial versus medical-grade oxygen. With the experiences of the last six months in particular, when it appeared as though almost any grade of oxygen would do to meet insatiable demand in India for example, one might argue whether the ‘taboo’ topic of medical oxygen purity is now in question. Could barriers have been broken in our traditional understanding of what medical oxygen is or should be?
... to continue reading you must be subscribed
